About PPA   |   Sign In   |   Join Now
PPA Medical Cannabis


The website is designed to help the practicing pharmacist manage patient drug therapy when a patient is also taking medical cannabis. This website is intended to provide information and guidance to the pharmacist who is identifying and resolving adverse effects and drug interactions that may occur in patients using medical cannabis to treat a disease or alleviate symptoms. 


This page was developed by the Medical Cannabis Working group of the Pennsylvania Pharmacist Association.  Members of this group included:


Andrew M. Peterson, PharmD, PhD, FCPP - Chair

Bethany Abrahams, PharmD

Andrew Dick, PharmD

Janet Hart, RPh.

Eric Hauser, RPh

Mary Mihalyo, BS, PharmD, BCPS

Lindsey Meston, PharmD

Christine Roussel, PharmD

Brian Walker, RPh

Rebecca Wise, MEd, PharmD, BCGP


Please refer to this page often for updates, as the area of medical cannabis is constantly evolving.








List of Approved Indications in PA (as of June 2019). For updates on this conditions, please see the PA Department of Health Medical Marijuana Patient and Caregiver Resources page.


Only patients with serious medical conditions are eligible to receive medical cannabis under the current PA Commonwealth law. A "serious medical condition" under the law is any one of the following:


Cancer, including remission therapy  Terminal Illness HIV/AIDS 
Amyotrophic lateral Sclerosis  Parkinson's disease

Multiple sclerosis 

Huntington's disease
Neurodegenerative diseases
Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity, and other associated neuropathies
Neuropathies  Dyskinetic and spastic movement disorders  Epilepsy 
Intractable seizures
Post-traumatic stress disorder
Tourette Syndrome Glaucoma 
Crohn's disease
Inflammatory bowel disease
Sickle cell anemia

Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain


Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjunctive therapy is indicated in combination with primary therapeutic interventions;




Association Management Software Powered by YourMembership  ::  Legal